LOU; Yan
Patent Applications and Registrations
Patent applications and USPTO patent grants for LOU; Yan.The latest application filed is for "tricyclic derivatives as hypoxia inducible factor-2(alpha) inhibitors".
Company Profile
22.68.83
- LOU; Yan - Pleasanton CA
- LOU; Yan - Wilmington DE
- Lou; Yan - Pleasonton CA
- Lou; Yan - Fremont CA
- LOU; Yan - Emeryville CA US
- Lou; Yan - Panzhihua CN
- Lou; Yan - Glen Ridge NJ
- Lou; Yan - Clifton NJ
- - Glen Ridge NJ US
- Lou; Yan - San Jose CA
Patent Activity
| Patent | Date |
|---|---|
| Tricyclic Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20220274914 - FU; Jiping ; et al. | 2022-09-01 |
| Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases Grant 11,420,936 - Fu , et al. August 23, 2 | 2022-08-23 |
| Condensed Heterocyclic Derivates As Bcl-2 Inhibitors For The Treatment Of Neoplastic Diseases App 20220220126 - Chen; Yi ; et al. | 2022-07-14 |
| BCL-2 inhibitors Grant 11,365,206 - Chen , et al. June 21, 2 | 2022-06-21 |
| Hypoxia Inducible Factor-2(alpha) Inhibitors And Their Use In The Treatment Of Diseases App 20220185771 - FU; Jiping ; et al. | 2022-06-16 |
| Fused Polycyclic Pyridone Compounds As Influenza Virus Replication Inhibitors App 20220177487 - FU; Jiping ; et al. | 2022-06-09 |
| Tetrahydro-1h-cyclopenta[cd]indene Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20220162158 - FU; Jiping ; et al. | 2022-05-26 |
| Process Of Preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahyd- Ro-1h-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile App 20220119345 - FU; Jiping ; et al. | 2022-04-21 |
| Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases Grant 11,279,711 - Chen , et al. March 22, 2 | 2022-03-22 |
| Immunoproteasome Inhibitors App 20220073538 - Lou; Yan ; et al. | 2022-03-10 |
| Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2.alpha. inhibitors Grant 11,267,782 - Fu , et al. March 8, 2 | 2022-03-08 |
| 2,3-DIHYDROBENZO[b]THIOPHENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS App 20220054451 - FU; Jiping ; et al. | 2022-02-24 |
| Immunoproteasome inhibitors Grant 11,225,493 - Lou , et al. January 18, 2 | 2022-01-18 |
| Indane Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20210380536 - FU; Jiping ; et al. | 2021-12-09 |
| Tri-substituted Heteroaryl Derivatives As Src Homology-2 Phosphate Inhibitors App 20210380604 - FU; Jiping ; et al. | 2021-12-09 |
| Adenosine Receptor Binding Compounds App 20210355104 - LOU; Yan ; et al. | 2021-11-18 |
| Tetrahydro-1h-cyclopenta[cd]indene Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20210347729 - FU; Jiping ; et al. | 2021-11-11 |
| Immunoproteasome inhibitors Grant 11,154,563 - Lou , et al. October 26, 2 | 2021-10-26 |
| Tetrahydro-1h-cyclopenta[cd]indene Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20210246102 - FU; Jiping ; et al. | 2021-08-12 |
| Fused Tricyclic Ring Derivatives As Src Homology-2 Phosphate Inhibitors App 20210188876 - FU; Jiping ; et al. | 2021-06-24 |
| Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors Grant 11,034,705 - Fu , et al. June 15, 2 | 2021-06-15 |
| Bcl-2 Inhibitors App 20210171523 - Chen; Yi ; et al. | 2021-06-10 |
| Fused Tricyclic Ring Derivatives As Src Homology-2 Phosphate Inhibitors App 20210040122 - FU; Jiping ; et al. | 2021-02-11 |
| Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors Grant 10,894,797 - Fu , et al. January 19, 2 | 2021-01-19 |
| Tetrahydro-1h-cyclopenta[cd]indene Derivatives As Hypoxia Inducible Factor-2(alpha) Inhibitors App 20200361855 - FU; Jiping ; et al. | 2020-11-19 |
| Covalent Inhibitors Of Cdk-7 App 20200297724 - Chen; Yi ; et al. | 2020-09-24 |
| Immunoproteasome Inhibitors App 20200277312 - Lou; Yan ; et al. | 2020-09-03 |
| Fused Tricyclic Ring Derivatives As Src Homology-2 Phosphatase Inhibitors App 20200277308 - FU; Jiping ; et al. | 2020-09-03 |
| Novel Therapeutic Agents For The Treatment Of Hbv Infection App 20200223841 - Chen; Yi ; et al. | 2020-07-16 |
| Biaryl amide compounds as kinase inhibitors Grant 10,709,712 - Aversa , et al. | 2020-07-14 |
| Bcl-2 Inhibitors App 20200197406 - Chen; Yi ; et al. | 2020-06-25 |
| Condensed Heterocyclic Derivates As Bcl-2 Inhibitors For The Treatment Of Neoplastic Diseases App 20200190109 - Chen; Yi ; et al. | 2020-06-18 |
| Fused Tricyclic Ring Derivatives As Src Homology-2 Phosphatase Inhibitors App 20200115389 - Fu; Jiping ; et al. | 2020-04-16 |
| Bcl-2 Inhibitors App 20200071329 - Chen; Yi ; et al. | 2020-03-05 |
| Therapeutic agents for the treatment of HBV infection Grant 10,501,456 - Chen , et al. Dec | 2019-12-10 |
| Immunoproteasome Inhibitors App 20190336515 - Lou; Yan ; et al. | 2019-11-07 |
| Covalent inhibitors of CDK-7 Grant 10,456,397 - Chen , et al. Oc | 2019-10-29 |
| Compounds and compositions as kinase inhibitors Grant 10,392,404 - Barsanti , et al. A | 2019-08-27 |
| BCL-2 inhibitors Grant 10,377,755 - Chen , et al. A | 2019-08-13 |
| Biaryl Amide Compounds As Kinase Inhibitors App 20190175606 - AVERSA; Robert John ; et al. | 2019-06-13 |
| Novel Therapeutic Agents For The Treatment Of Hbv Infection App 20190169182 - Chen; Yi ; et al. | 2019-06-06 |
| Covalent Inhibitors Of Cdk-7 App 20190151316 - Chen; Yi ; et al. | 2019-05-23 |
| Dual-warhead covalent inhibitors of FGFR-4 Grant 10,253,029 - Chen , et al. | 2019-04-09 |
| Biaryl amide compounds as kinase inhibitors Grant 10,245,267 - Aversa , et al. | 2019-04-02 |
| Therapeutic agents for the treatment of HBV infection Grant 10,239,872 - Chen , et al. | 2019-03-26 |
| Bcl-2 Inhibitors App 20190040062 - Chen; Yi ; et al. | 2019-02-07 |
| Covalent inhibitors of CDK-7 Grant 10,195,200 - Chen , et al. Fe | 2019-02-05 |
| Compounds and compositions as RAF kinase inhibitors Grant 10,167,279 - Aversa , et al. J | 2019-01-01 |
| Tetrahydro-benzodiazepinones Grant 10,053,431 - Chen , et al. August 21, 2 | 2018-08-21 |
| Novel Therapeutic Agents For The Treatment Of Hbv Infection App 20180170925 - Chen; Yi ; et al. | 2018-06-21 |
| Compounds And Compositions As Raf Kinase Inhibitors App 20180170917 - AVERSA; Robert John ; et al. | 2018-06-21 |
| Covalent Inhibitors Of Cdk-7 App 20180008604 - Chen; Yi ; et al. | 2018-01-11 |
| Inhibitors of bruton's tyrosine kinase Grant 9,802,920 - Dominique , et al. October 31, 2 | 2017-10-31 |
| Dual-warhead Covalent Inhibitors Of Fgfr-4 App 20170305918 - Chen; Yi ; et al. | 2017-10-26 |
| Compounds And Compositions As Kinase Inhibitors App 20170260200 - BARSANTI; Paul Andrew ; et al. | 2017-09-14 |
| Biaryl Amide Compounds As Kinase Inhibitors App 20170260207 - AVERSA; Robert John ; et al. | 2017-09-14 |
| Biaryl amide compounds as kinase inhibitors Grant 9,694,016 - Aversa , et al. July 4, 2 | 2017-07-04 |
| Antiproliferative benzo [B] azepin-2-ones Grant 9,611,224 - Han , et al. April 4, 2 | 2017-04-04 |
| Inhibitors of bruton's tyrosine kinase Grant 9,556,147 - Brotherton-Pleiss , et al. January 31, 2 | 2017-01-31 |
| Inhibitors of bruton's tyrosine kinase Grant 9,556,150 - Lopez-Tapia , et al. January 31, 2 | 2017-01-31 |
| Inhibitors of bruton's tyrosine kinase Grant 9,499,548 - Brotherton-Pleiss , et al. November 22, 2 | 2016-11-22 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20160311801 - Lopez-Tapia; Francisco Javier ; et al. | 2016-10-27 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20160304497 - Dominique; Romyr ; et al. | 2016-10-20 |
| Tetrahydro-benzodiazepinones App 20160272596 - Chen; Shaoqing ; et al. | 2016-09-22 |
| Azaheterocycles as BIR2 and/or BIR3 inhibitors Grant 9,422,332 - Hogg , et al. August 23, 2 | 2016-08-23 |
| 2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer Grant 9,422,331 - Donnell , et al. August 23, 2 | 2016-08-23 |
| Substituted hetero-azepinones Grant 9,394,263 - Donnell , et al. July 19, 2 | 2016-07-19 |
| Azaindolines Grant 9,340,573 - Hogg , et al. May 17, 2 | 2016-05-17 |
| Biaryl Amide Compounds As Kinase Inhibitors App 20160038504 - AVERSA; Robert John ; et al. | 2016-02-11 |
| Biaryl amide compounds as kinase inhibitors Grant 9,242,969 - Barsanti , et al. January 26, 2 | 2016-01-26 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20160002206 - Brotherton-Pleiss; Christine E. ; et al. | 2016-01-07 |
| Substituted Hetero-azepinones App 20150361059 - Donnell; Andrew F. ; et al. | 2015-12-17 |
| Antiproliferative Benzo [b] Azepin-2-ones App 20150353499 - Han; Xiaochun ; et al. | 2015-12-10 |
| Metal protection coating, hot-dip Zn metallic material and hot-dip Al--Zn metallic material using the same Grant 9,181,447 - Xu , et al. November 10, 2 | 2015-11-10 |
| Azaindolines App 20150252072 - Hogg; Joan Heather ; et al. | 2015-09-10 |
| 2-oxo-2,3,4,5-tetrahydro-1 H-benzo[b]diazepines And Their Use In The Treatment Of Cancer App 20150225449 - Donnell; Andrew Forrest ; et al. | 2015-08-13 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20150210704 - Brotherton-Pleiss; Christine E. ; et al. | 2015-07-30 |
| Azaheterocycles As Bir2 And/or Bir3 Inhibitors App 20150210739 - Hogg; Joan Heather ; et al. | 2015-07-30 |
| Inhibitors of bruton's tyrosine kinase Grant 8,940,741 - Berthel , et al. January 27, 2 | 2015-01-27 |
| Inhibitors of bruton'S tyrosine kinase Grant 8,889,682 - Brotherton-Pleiss , et al. November 18, 2 | 2014-11-18 |
| Biaryl Amide Compounds As Kinase Inhibitors App 20140275003 - Barsanti; Paul A. ; et al. | 2014-09-18 |
| Inhibitors of bruton's tyrosine kinase Grant 8,822,457 - Dewdney , et al. September 2, 2 | 2014-09-02 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20140194413 - Dewdney; Nolan James ; et al. | 2014-07-10 |
| Pyrrolopyrazine Kinase Inhibitors App 20140155376 - Hendricks; Robert Than ; et al. | 2014-06-05 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,742,098 - Brotherton-Pleiss , et al. June 3, 2 | 2014-06-03 |
| Inhibitors of bruton's tyrosine kinase Grant 8,729,078 - Billedeau , et al. May 20, 2 | 2014-05-20 |
| Inhibitors of bruton's tyrosine kinase Grant 8,618,098 - Dewdney , et al. December 31, 2 | 2013-12-31 |
| Inhibitors of bruton's tyrosine kinase Grant 08618098 - | 2013-12-31 |
| Inhibitors of Burton's tyrosine kinase Grant 8,536,166 - Dewdney , et al. September 17, 2 | 2013-09-17 |
| Pyrrolopyrazine kinase inhibitors Grant 8,518,945 - Hendricks , et al. August 27, 2 | 2013-08-27 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20130178461 - Berthel; Steven Joseph ; et al. | 2013-07-11 |
| Inhibitors of bruton's tyrosine kinase Grant 8,481,540 - Berthel , et al. July 9, 2 | 2013-07-09 |
| Pyrrolopyrazine kinase inhibitors Grant 8,481,541 - Hendricks , et al. July 9, 2 | 2013-07-09 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20130150360 - Brotherton-Pleiss; Christine E. ; et al. | 2013-06-13 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,426,409 - Kondru , et al. April 23, 2 | 2013-04-23 |
| Inhibitors of bruton's tyrosine kinase Grant 8,426,441 - Dewdney , et al. April 23, 2 | 2013-04-23 |
| Metal Protection Coating, Hot-dip Zn Metallic Material And Hot-dip Al-zn Metallic Material Using The Same App 20130078456 - Xu; Zhefeng ; et al. | 2013-03-28 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20130045965 - Brotherton-Pleiss; Christine E. ; et al. | 2013-02-21 |
| Pyrrolopyrazine kinase inhibitors Grant 8,329,699 - Hendricks , et al. December 11, 2 | 2012-12-11 |
| Inhibitors of bruton's tyrosine kinase Grant 8,324,211 - Dewdney , et al. December 4, 2 | 2012-12-04 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,318,719 - Dewdney , et al. November 27, 2 | 2012-11-27 |
| Inhibitors Of Bruton's Tyrosine Kinase App 20120295885 - Billedeau; Roland Joseph ; et al. | 2012-11-22 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,299,077 - Berthel , et al. October 30, 2 | 2012-10-30 |
| Inhibitors of Bruton's Tyrosine Kinase App 20120129845 - Dewdney; Nolan James ; et al. | 2012-05-24 |
| Inhibitors of bruton's tyrosine kinase Grant 8,124,604 - Dewdney , et al. February 28, 2 | 2012-02-28 |
| Pyrrolopyrazine kinase inhibitors Grant 8,119,636 - DuBois , et al. February 21, 2 | 2012-02-21 |
| Inhibitors of Bruton's Tyrosine Kinase App 20120040949 - Berthel; Steven Joseph ; et al. | 2012-02-16 |
| Pyrrolopyrazine Kinase Inhibitors App 20110288097 - Hendricks; Robert Than ; et al. | 2011-11-24 |
| Pyrrolopyrazine Kinase Inhibitors App 20110288067 - Hendricks; Robert Than ; et al. | 2011-11-24 |
| Pyrrolopyrazine Kinase Inhibitors App 20110230462 - Hendricks; Robert Than ; et al. | 2011-09-22 |
| Pyrrolopyrazine Kinase Inhibitors App 20110230414 - Hendricks; Robert Than ; et al. | 2011-09-22 |
| Pyrrolopyrazine kinase inhibitors Grant 8,008,298 - Bamberg , et al. August 30, 2 | 2011-08-30 |
| Btk protein kinase inhibitors Grant 7,943,618 - Dewdney , et al. May 17, 2 | 2011-05-17 |
| Pyrrolopyrazine kinase inhibitors Grant 7,939,531 - Bamberg , et al. May 10, 2 | 2011-05-10 |
| Inhibitors of Bruton's Tyrosine Kinase App 20110105479 - Dewdney; Nolan James ; et al. | 2011-05-05 |
| Pyrrolopyrazine kinase inhibitors Grant 7,932,254 - DuBois , et al. April 26, 2 | 2011-04-26 |
| Inhibitors of bruton's tyrosine kinase Grant 7,906,509 - Kennedy-Smith , et al. March 15, 2 | 2011-03-15 |
| Inhibitors of bruton's tyrosine kinase Grant 7,902,194 - Dewdney , et al. March 8, 2 | 2011-03-08 |
| Pyrrolopyrazine kinase inhibitors Grant 7,902,197 - Elworthy , et al. March 8, 2 | 2011-03-08 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100273768 - Dewdney; Nolan James ; et al. | 2010-10-28 |
| Pyrrolopyrazine kinase inhibitors App 20100267666 - Bamberg; Joe Timothy ; et al. | 2010-10-21 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100222325 - Berthel; Steven ; et al. | 2010-09-02 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100099659 - Kennedy-Smith; Joshua ; et al. | 2010-04-22 |
| Inhibitors of Bruton's tyrosine kinase Grant 7,683,064 - Dewdney , et al. March 23, 2 | 2010-03-23 |
| Inhibitors of bruton's tyrosine kinase App 20100016302 - Kondru; Rama K. ; et al. | 2010-01-21 |
| Inhibitors of bruton's tyrosine kinase App 20100016301 - Dewdney; Nolan James ; et al. | 2010-01-21 |
| Inhibitors Of Burton's Tyrosine Kinase App 20100004231 - Dewdney; Nolan James ; et al. | 2010-01-07 |
| Inhibitors of Bruton's Tyrosine Kinase App 20090318448 - Dewdney; Nolan James ; et al. | 2009-12-24 |
| Inhibitors of Bruton's tyrosine kinase App 20090306041 - Dewdney; Nolan James ; et al. | 2009-12-10 |
| Pyrrolopyrazine kinase inhibitors App 20090215785 - DuBois; Daisy Joe ; et al. | 2009-08-27 |
| Pyrrolopyrazine kinase inhibitors App 20090215724 - DuBois; Daisy Joe ; et al. | 2009-08-27 |
| Pyrrolopyrazine kinase inhibitors App 20090215788 - Elworthy; Todd Richard ; et al. | 2009-08-27 |
| Pyrrolopyrazine kinase inhibitors App 20090215750 - Bamberg; Joe Timothy ; et al. | 2009-08-27 |
| Inhibitors of bruton's tyrosine kinase App 20090186898 - Dewdney; Nolan James ; et al. | 2009-07-23 |
| Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors Grant 7,563,800 - Gabriel , et al. July 21, 2 | 2009-07-21 |
| BTK protein kinase inhibitors App 20090105209 - Dewdney; Nolan James ; et al. | 2009-04-23 |
| Kinase inhibitors and methods for using the same App 20080207684 - Gabriel; Tobias ; et al. | 2008-08-28 |
| P38 map kinase inhibitors and methods for using the same App 20080146590 - Gabriel; Tobias ; et al. | 2008-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 